During the past decade, Ningbo Women and Children's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ningbo Women and Children's Hospital" #1 sponsor was "Children's Hospital of Chongqing Medical University" with 1 trials, followed by "Children's Hospital of Fudan University" with 1 trials sponsored, "Danone Nutricia" with 1 trials sponsored, "GeneScience Pharmaceuticals Co., Ltd." with 1 trials sponsored and "I-Mab Biopharma Co. Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ningbo Women and Children's Hospital" #1 collaborator was "Ningbo Women & Children's Hospital" with 2 trials as a collaborator, "Central South University" with 1 trials as a collaborator, "First Affiliated Hospital of Guangxi Medical University" with 1 trials as a collaborator, "First People's Hospital of Hangzhou" with 1 trials as a collaborator and "Foshan Maternity and Child Health Care Hospital" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Ningbo Women and Children's Hospital" are "Apnea of Prematurity" (1 trials), "Breast Neoplasm" (1 trials), "Caffeine" (1 trials), "Encephalopathy" (1 trials) and "Growth Hormone Deficiency" (1 trials). Many other conditions were trialed in "Ningbo Women and Children's Hospital" in a lesser frequency.

Most popular intervention types in "Ningbo Women and Children's Hospital" are "Drug" (5 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT]" (1 trials), "Epirubicin plus Cyclophosphamide" (1 trials), "Matching placebo" (1 trials), "NordiFlex" (1 trials) and "PEG-somatropin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ningbo Women and Children's Hospital" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ningbo Women and Children's Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ningbo Women and Children's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ningbo Women and Children's Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".